References
- Abe, T. : Clinical studies of the vitamins. Jpn. Soc. Inter. Med. 54, 989-1006 (1965) https://doi.org/10.2169/naika.54.989
- Attele, A. S., Wu, J. A. and Yuan, C. S. : Ginseng pharmacology: multiple onstituents and multiple actions. Biochem. Pharmacol. 58, 1685-1693 (1999) https://doi.org/10.1016/S0006-2952(99)00212-9
- Kudo, K., Tachikawa, E., Kashimoto, T. and Takahashi, E. : Properties of ginseng saponin inhibition of catecholamine secretion in bovine chromaffin cells. Eur. J. Pharmacol. 341, 139-144 (1998) https://doi.org/10.1016/S0014-2999(97)01350-2
- Choi, S., lung, S. Y., Lee, J. H., Sala, F., Criado, M., Mulet, J., Valor, L. M., Sala, S., Engel, A. G. and Nah, S. Y. : Effects of ginsenosides, active components of ginseng, on nicotinic acetylcholine receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 442, 37-45 (2002) https://doi.org/10.1016/S0014-2999(02)01508-X
-
Sala, F., Mulet, J., Choi, S., lung, S. Y., Nah, S. Y., Rhim, H., Valor, L. M., Criado, M. and Sala, S. : Effects of ginsenoside
$Rg_2$ on human neuronal nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 301, 1052-1059 (2002) https://doi.org/10.1124/jpet.301.3.1052 -
Karikura, M., Miyase, T, Tanizawa, H., Taniyawa, T. and Takino, Y. : Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside
$Rb_1$ and$Rb_2$ in the digestive tract of rats. Chem. Pharm. Bull. 39, 400-404 (1991) https://doi.org/10.1248/cpb.39.400 - Kanaoka, M., Akao, T. and Kobashi, K. : Metabolism of ginseng saponins, ginsenosides by human intestinal flora. J. Trad. Med. 11, 241-245 (1994)
- Wakabayashi, C., Hasegawa, H., Murata, J. and Saiki, I. : In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oneol. Res. 9, 411-417 (1997)
- Wakabayashi, C., Murakami, K, Hasegawa, H., Murata, J. and Saiki, I. : An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem. Biophys. Res. Commun. 249, 725-730 (1998)
- Ortells, M. O. and Lunt, G G : Evolutionary history of the ligand-gated on channel superfamily of receptors. Trends Neurosci. 18, 121-127 (1995) https://doi.org/10.1016/0166-2236(95)93887-4
-
Jackson, M. B. and Yakel, J. L. : The 5-
$HT_3$ receptor channel. Annu. Rev. Physiol. 57, 447-468 (1995) https://doi.org/10.1146/annurev.ph.57.030195.002311 -
Lucot, J. B. : Blockade of 5-
$hydroytryptamine_3$ receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat. Pharmacol. Biochem. Behav. 32, 207-210 (1989) https://doi.org/10.1016/0091-3057(89)90235-9 -
Schworer, H., Racke, K. and Kilbinger, H. : Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guineapig-involvement of 5-
$HT_3$ receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 143-149 (1991) - King, G. L.: Animal models in the study of vomiting. Can. J. Physiol. Pharmacol. 68,260-268 (1990) https://doi.org/10.1139/y90-040
-
Dang, H., England, P. M., Farivar, S. S., Dougherty, D. A. and Lester, H. A. : Probing the role of a conserved Ml proline residue in 5
$hydroytryptamine_3$ receptor gating. Mol. Pharmacol. 57, 1114-1122 (2000) - Arias, H. R. : Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol. Membr. Biol. 13, 1-17 (1996) https://doi.org/10.3109/09687689609160569
- Heidman, T, Oswald, R. E. and Changeux, J. P. : Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry 22, 3112-3127 (1983) https://doi.org/10.1021/bi00282a014
- Sine, S. M. and Taylor, P. : Local anesthetic and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. J. Biol. Chem. 257, 8106-8114 (1982)
- Fortney, J. T, Gan, T. J., Graczyk, S., Wetchler, B., Melson, T., Kahlil, S., Mckenzie, R., Pamillo, S., Glass, P. S., Moote, C., Wermeling, D., Parasuraman, T. V., Duncan, B. and Creed, M. R. : A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth. Analg. 86, 731-738 (1998) https://doi.org/10.1097/00000539-199804000-00011
- Perez, E. A. and Gandara, D. R. : Advances in the control of chemotherapy-induced emesis. Ann. Oncol. 3 Suppl. 3, 47-50 (1992)
- Polati, E., Verlato G., Finco, G., Monsaner, W., Grosso, S., Gottin, L., Pinaroli, A. M. and Ischia, S. : Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. Anesth. Analg. 85, 395-399 (1997) https://doi.org/10.1097/00000539-199708000-00027
- Chevallier, B. : The control of acute cisplatin-induced emesis a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Br. J. Cancer 68, 176-180 (1993) https://doi.org/10.1038/bjc.1993.309
-
Lee, B.-H., Lee, J.-H., Jung, S.-M., Kim, D.-H., Kim, J.-H., Kim, J.-I., Lee, S.-M. and Na, S.-Y. : Differential Effect of Ginsenoside Metabolites on the 5-
$HT_3A$ Receptor-Mediated Ion Current in Xenopus Oocytes. Mol. Cells, 17, 1, 51-56 (2004)